成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Struktur
2088771-61-1
CAS-Nr.
2088771-61-1
Englisch Name:
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
Synonyma:
Impurity FP-B;Sitagliptin-17;Sitagliptin Impurity 20;Sitagliptin FP Impurity B;Sitagliptin Impurity FP-B;Sitagliptin Triazecine Impurity;(R)-Sitagliptin Tablets EP Impurity FP-B;(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl);Sitagliptin FP Impurity B/ Sitagliptin Triazecine Analog;(R)-Sitagliptin Tablets EP Impurity FP-B ((R)-Sitagliptin Triazecine Analog)
CBNumber:
CB23371367
Summenformel:
C16H13F6N5O2
Molgewicht:
421.3
MOL-Datei:
2088771-61-1.mol

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Eigenschaften

Schmelzpunkt:
>189°C (dec.)
Dichte
1.67±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer, Under inert atmosphere
L?slichkeit
DMSO (Slightly), Methanol (Slightly)
pka
12.02±0.40(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
InChI
InChI=1S/C16H13F6N5O2/c17-9-6-11(19)10(18)4-7(9)3-8-5-12(28)23-1-2-27-13(14(29)24-8)25-26-15(27)16(20,21)22/h4,6,8H,1-3,5H2,(H,23,28)(H,24,29)/t8-/m1/s1
InChIKey
CJUCSNDPMOGZTM-MRVPVSSYSA-N
SMILES
N1[C@H](CC2=CC(F)=C(F)C=C2F)CC(=O)NCCN2C(C(F)(F)F)=NN=C2C1=O

Sicherheit

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(10R)-Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 68)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
16314854226; +16314854226
 inquiry@bocsci.com United States 19741 58
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14332 58
Finetech Industry Limited 		+86-27-87465837 +8618971612321
 info@finetechnology-ind.com China 9639 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3148 58
sgtlifesciences pvt ltd 		+8617013299288
 dj@sgtlifesciences.com China 12373 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
Zibo Hangyu Biotechnology Development Co., Ltd 		+86-0533-2185556 +8617865335152
 Mandy@hangyubiotech.com China 10986 58
Guangzhou CATO Research Chemicals Inc. 		+86-020-81960175-617 +8615602392859
 Intermediate@cato-chem.com China 5763 58
Moxin Chemicals 		+8617320513646
 mike@molcoo.com China 9558 58
Shanghai Payne Pharmaceutical Technology Co.Ltd 		021-58123769 18678586262
 info@paynepharm.com China 1354 58

2088771-61-1()Verwandte Suche:

  • Impurity FP-B
  • Sitagliptin Impurity 20
  • Sitagliptin-17
  • Sitagliptin FP Impurity B
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)
  • Sitagliptin impurity 6/Sitagliptin FP Impurity B/Sitagliptin Triazecine Analog/10-(2,4,5-Trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro [1,2,4] triazolo [3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • 1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-, (10R)-
  • (10R)?- 6,?7,?10,?11-?Tetrahydro-?3-?(trifluoromethyl)?-?10-?[(2,?4,?5-?trifluorophenyl)?methyl]?-1,?2,?4-?triazolo[3,?4-?c]?[1,?4,?7]?triazecine-?8,?12(5H,?9H)?-?dione
  • Sitagliptin FP Impurity B/ Sitagliptin Triazecine Analog
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione
  • Sitagliptin Impurity FP-B
  • (R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione? (Sitagliptin Impurity）
  • (10R)-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-5H,6H,7H,8H,9H,10H,11H,12H-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12-dione
  • (R)-Sitagliptin Tablets EP Impurity FP-B
  • Sitagliptin Triazecine Impurity
  • (R)-Sitagliptin Tablets EP Impurity FP-B ((R)-Sitagliptin Triazecine Analog)
  • 1,2,4-Triazolo[3,4- c ][1,4,7]triazecine-8,12(5 H ,9 H )-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-, (10 R )-/Sitagliptin Triazecine Analog
  • 2088771-61-1
  • C16H13F6N5O2
Copyright 2019 ? ChemicalBook. All rights reserved